Source link : https://www.newshealth.biz/health-news/encouraging-early-data-for-mrna-vaccine-in-glioblastoma/
BARCELONA — In a first-in-human clinical trial, an investigational messenger RNA (mRNA)-based cancer vaccine for glioblastoma induced tumor-associated antigen-specific T-cell responses in more than three quarters of patients and had an acceptable safety profile. “These early data are encouraging,” Ghazaleh Tabatabai, MD, PhD, University Hospital Tübingen, Germany, said in a news release from CureVac, which […]
Author : News Health
Publish date : 2024-09-13 18:44:12
Copyright for syndicated content belongs to the linked Source.